Send this to a friend

CT company wins up to $9.4M contract for Anthrax testing tech

Branford’s Tangen Biosciences has won a federal contract valued at up to $9.4 million to develop an Anthrax diagnostic test.

The contract from the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) will advance the ability to combat the threat of Anthrax, a potentially deadly bacteria that can cause skin, lung and other diseases, by utilizing Tangen’s TangenDx Molecular Diagnostic System. The syste ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media